Amy Fleischman, MD, MMSc
Director, Optimal Wellness for Life (OWL) Program; Director, Clinical Operations, Division of Endocrinology; Attending Physician, Division of Endocrinology
Assistant Professor of Pediatrics, Harvard Medical School
Image
Amy Fleischman, MD, MMSc
Director, Optimal Wellness for Life (OWL) Program; Director, Clinical Operations, Division of Endocrinology; Attending Physician, Division of Endocrinology
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Yale University
1994
New Haven
CT
Graduate School
MMSc
Harvard University / Massachusetts Institute of Technology
Cambridge
MA
Medical School
Johns Hopkins School of Medicine
1998
Baltimore
MD
Internship
Pediatrics
Boston Combined Residency Program (BCRP)
1999
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2001
Boston
MA
Fellowship
Pediatric Endocrinology
Boston Children's Hospital
2005
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Endocrinology)
Publications
Overfeeding and overweight rapidly reprogram inflammatory signaling. View Abstract
Long-Term Follow-up of an Infant with Prader-Willi Syndrome. View Abstract
Implementation of recommended treatment for children in weight management programs: Lessons from the stay in treatment study sites. View Abstract
How much did it cost to develop and implement an eHealth intervention for a minority children population that overlapped with the COVID-19 pandemic? View Abstract
Fitness [BULLET OPERATOR] Interdisciplinary Support [BULLET OPERATOR] Teaching ("Fit Start"); Piloting A Family-based Group Model For The Multidisciplinary Treatment Of Pediatric Obesity: 306 Board #143 June 1, 9: 30 AM - 11: 00 AM. View Abstract
An intensive outpatient lifestyle modification programme improves measures of glycaemia in obese youth. View Abstract
Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. View Abstract
Skeletal muscle mitochondrial function is associated with longitudinal growth velocity in children and adolescents. View Abstract
Recombinant human prolactin for the treatment of lactation insufficiency. View Abstract
Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults. View Abstract
Insulin enhances glucose-stimulated insulin secretion in healthy humans. View Abstract
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy. View Abstract
Mitochondrial function and insulin resistance in overweight and normal-weight children. View Abstract
Salsalate improves glycemia and inflammatory parameters in obese young adults. View Abstract
Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia. View Abstract
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. View Abstract
Bone mineral status in children with congenital adrenal hyperplasia. View Abstract
Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. View Abstract
Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance. View Abstract
Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. View Abstract
Carbamazepine overdose recognized by a tricyclic antidepressant assay. View Abstract
Long term human studies on the lipid effects of oral calcium. View Abstract
Variation in plasma lipids with age and sex in a hypertriglyceridemic rat. View Abstract
Serum lipids and certain dietary factors in young men with coronary heart disease. View Abstract